US Drug Recall Register
Class III · Low risk Terminated Initiated Jan 22, 2020 (7 years ago)

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications: low out of specification results for dissolution testing.

What was recalled

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

Recalling firm
Ascend Laboratories LLC
NDC code
67877-438-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0827-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all